National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 38195 [2016-13828]
Download as PDF
<![CDATA[
srobinson on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices
• Tell NIDA how you design
scientific experiments in general.
Amount of the Prize; Award
Approving Official. Up to ten monetary
prizes will be awarded. The total prize
award pool is up to $100,000. No
institutional indirect costs are allowed.
The names of the winners and the titles
of their submissions will be posted on
the NIDA Web site. The award
approving official for this Challenge is
the Director of the National Institute on
Drug Abuse.
Payment of the Prize. Prizes awarded
under this Challenge will be paid by
electronic funds transfer and may be
subject to Federal income taxes. The
NIH/NIDA will comply with the
Internal Revenue Service withholding
and reporting requirements, where
applicable.
Basis upon Which the Winner Will Be
Selected. The judging panel will make
recommendations to the award
approving official based upon the
following 5 criteria. Each criterion will
be scored with the maximum of 10
points.
(1) Significance and Unmet Needs (0–
10 points). Are there significant needs
for your product or service? Does the
project address an important problem or
a critical barrier to progress in the field
of drug abuse research? If the aims of
the project are achieved, how will
scientific knowledge, technical
capability, service or clinical practice be
improved?
(2) Innovation (0–10 points). Does the
submission seek to shift current
paradigms by utilizing novel theoretical
concepts, approaches, methodologies,
instrumentation, service or
interventions for drug abuse research? Is
your product novel in a broad sense? Is
a refinement, improvement or new
application of theoretical concepts,
approaches or methodologies
instrumentation or interventions
proposed?
(3) Approach (0–10 points). Are the
overall strategy, methodology, and
analyses well-reasoned and appropriate
to test the proposed idea? Has feedback
from end users been incorporated into
the validity of the idea proposed?
(4) Team expertise (0–10 points). Does
the individual or team demonstrate high
level of ability, perseverance and grit?
(5) Commercialization (0–10 points).
Is there a clear path for the product/
service to reach the market? Are the
product users and purchasers clearly
identified?
Submissions that are responsive and
comply with the entry requirements will
be reviewed by a panel of judges
consisting of federal employees. The
responsive and compliant submissions
VerDate Sep<11>2014
20:48 Jun 10, 2016
Jkt 238001
entries will be scored in accordance
with the judging criteria outlined above.
Final recommendations will be
determined by a vote of the judges based
on score. Scores from each criterion will
be weighted equally, but failure to meet
a minimum standard for any one
criterion might disqualify a submission.
The score for each submission will be
the sum of the scores from each of the
voting judges.
Authority: 15 U.S.C. 3719
Dated: June 7, 2016.
Nora D. Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. 2016–13936 Filed 6–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA DK15–030
Type 1 Diabetes Pathfinder Award (DP2).
Date: July 14, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Program
Projects (P01).
Date: July 22, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
38195
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20817, 301–496–9010,
hoffertj@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Minor Endoscopic
Sphincterotomy for Recurrent Acute
Pancreatitis with Pancreas Divisum.
Date: July 25, 2016.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Psychological and
Behavioral Mechanisms in Bariatric Surgery
(R01).
Date: July 26, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: June 6, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–13828 Filed 6–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\13JNN1.SGM
13JNN1
]]>Agencies
[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13828]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA DK15-030 Type 1
Diabetes Pathfinder Award (DP2).
Date: July 14, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK Program Projects
(P01).
Date: July 22, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Jason D. Hoffert, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301-496-
9010, hoffertj@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Minor Endoscopic
Sphincterotomy for Recurrent Acute Pancreatitis with Pancreas
Divisum.
Date: July 25, 2016.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Paul A. Rushing, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Psychological and
Behavioral Mechanisms in Bariatric Surgery (R01).
Date: July 26, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Paul A. Rushing, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8895, rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: June 6, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13828 Filed 6-10-16; 8:45 am]
BILLING CODE 4140-01-P
